Stephen C. Glover - 11 Jun 2025 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
Director
Signature
/s/ Spencer Brown, as Attorney-in-Fact
Issuer symbol
PDSB
Transactions as of
11 Jun 2025
Net transactions value
$0
Form type
4
Filing time
11 Jun 2025, 18:00:33 UTC
Previous filing
03 Mar 2025
Next filing
15 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Glover Stephen C. Director C/O PDS BIOTECHNOLOGY CORPORATION, 303A COLLEGE ROAD EAST, PRINCETON /s/ Spencer Brown, as Attorney-in-Fact 11 Jun 2025 0001304406

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Employee Stock Option (Right to Buy) Award $0 +22,700 $0.000000 22,700 11 Jun 2025 Common Stock 22,700 $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.